ClC-3 Expression and Its Association with Hyperglycemia Induced HT22 Hippocampal Neuronal Cell Apoptosis

Area of Science:

• Neuroscience
• Molecular Biology
• Endocrinology

Background:

• Diabetic encephalopathy (DE) involves apoptosis, but molecular triggers are unclear.
• Understanding DE pathogenesis is crucial for therapeutic development.

Purpose of the Study:

• Investigate ClC-3 expression changes in hippocampal neurons under hyperglycemia.
• Determine the role of ClC-3 in high glucose-induced neuronal apoptosis in vitro.

Main Methods:

• HT22 hippocampal cells were exposed to varying glucose or mannitol concentrations.
• ClC-3 expression, cell viability, and apoptosis were measured via immunofluorescence, Western blot, MTT assay, and Flow Cytometry.
• The effect of a chloride channel blocker was assessed.

Main Results:

• Hyperglycemia significantly increased ClC-3 expression and neuronal apoptosis while reducing cell viability.
• Increased ClC-3 expression correlated with enhanced apoptosis.
• Mannitol (osmotic control) did not induce apoptosis.
• Chloride channel blocker treatment abolished hyperglycemia-induced apoptosis.

Conclusions:

• Increased ClC-3 expression is a key mechanism in hyperglycemia-induced hippocampal neuronal apoptosis.
• ClC-3 is a potential therapeutic target for diabetic encephalopathy.